INTRODUCTION
Recently, there has been controversy over endocrine disrupters amongst the general public as well as in dentistry. Among endocrine disrupters, bisphenol A (BPA) has been especially of great concern in dentistry as reviewed in a study published by the Japanese Society for Dental Materials and Devices1). The possible involvement of BPA in dentistry is in Bis-GMA-based resins such as composite resins, fissure sealants, and bonding agents and in polycarbonate (PC) products such as orthodontic brackets, temporary crowns and denture base resins. In the production of Bis-GMA and PC, BPA is used as a starting raw chemical. Therefore, it is possible that trace amounts of BPA is contained in the final products as an impurity. Actually, trace amounts of BPA were detected in Bis-GMA monomers and Bis-GMA-based resins2-4) as well as in polycarbonate dental materials5-7). The BPA contained in both types of materials will be released into the saliva in the oral cavity and should decrease with time if BPA is not produced within the materials.
The increase in the BPA content is not expected for Bis-GMA-based resins because the degradation of Bis-GMA to BPA is unlikely in the oral cavitya8). For PC, however, the increase in the BPA content and in the release is possible because the degradation of a PC can produce BPA. Recently, it was reported at the meetings of 
